Genvoya 150Mg-150Mg-200Mg-10Mg Tablet

DRUG2 trials

Sponsors

IRCCS San Raffaele, Henry M. Jackson Foundation for the Advancement of Military Medicine

Conditions

HIV InfectionsHIV-1-infection

Phase 3

Switch From Dual Regimens Based on Dolutegravir Plus a Reverse Transcriptase Inhibitor to E/C/F/TAF in Virologically Suppressed, HIV-1 Infected Patients (Be-OnE)

TerminatedNCT03493568

IRCCS San RaffaeleHIV-1-infection

Start: 2017-02-06End: 2020-07-31Updated: 2024-02-09

Unknown Phase

Antiretroviral Therapy for Acute HIV Infection

WithdrawnNCT03877536

Henry M. Jackson Foundation for the Advancement of Military MedicineHIV Infections

Start: 2019-03-17End: 2025-09-14Updated: 2019-04-26